Skip to main navigation Skip to search Skip to main content

Biostar: BG01-2402: A Pivotal Phase II Clinical Trial of Utidelone Injection (UTD1) Plus Capecitabine (CAP) in HER2- negative Breast Cancer Patients with Brain Metastases

Project: Research

Project Details

StatusActive
Effective start/end date04/10/2612/5/26

Funding

  • Novotech: $1.00